Occurrence of pharmaceuticals in rice (Oryza sativa L.) plant through wastewater irrigation.

The present investigation focuses on the identification of popular PhACs in roots, leaves and rice grains, which are cultivated in soil irrigated with waters and wastewater. The present study reveals the presence of PhACs in rice grains from different brands which are available in the current market, which has thus motivated these experiments. The rice plants were cultivated in garden containers and irrigated with three different water sources. All PhAC compounds were recovered within an 89-111 % range using the extraction technique, reproducibility, and sensitivity (LOQ <25 µg/g). Further, PhAC compounds were identified using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QqTOF-MS). Interestingly, several PhAC compounds were detected in rice grains, aligning with hypotheses and findings from published literature. A total of ten (10) PhACs were found in the root, leaf, and rice grain of the 20 popular PhACs that were targeted. The annual exposure and medical dose equivalent for individual PhACs was negligible. According to our knowledge, this study is the first to show the accumulation of several categories (cocktail) of PhACs in rice grains and show the approximate human health risk assessment by its consumption. The study's results provide valuable insights for researchers, policymakers, and agricultural practitioners working on sustainable agriculture and public health.

Removal of pharmaceutical compounds and toxicology study in wastewater using Malaysian fungal Ganoderma lucidum.

Elevated usage of pharmaceutical products leads to the accumulation of emerging contaminants in sewage. In the current work, Ganoderma lucidum (GL) was used to remove pharmaceutical compounds (PCs), proposed as a tertiary method in sewage treatment plants (STPs). The PCs consisted of a group of painkillers (ketoprofen, diclofenac, and dexamethasone), psychiatrists (carbamazepine, venlafaxine, and citalopram), beta-blockers (atenolol, metoprolol, and propranolol), and anti-hypertensives (losartan and valsartan). The performance of 800 mL of synthetic water, effluent STP, and hospital wastewater (HWW) was evaluated. Parameters, including treatment time, inoculum volume, and mechanical agitation speed, have been tested. The toxicity of the GL after treatment is being studied based on exposure levels to zebrafish embryos (ZFET) and the morphology of the GL has been observed via Field Emission Scanning Electron Microscopy (FESEM). The findings conclude that GL can reduce PCs from <10% to >90%. Diclofenac and valsartan are the highest (>90%) in the synthetic model, while citalopram and propranolol (>80%) are in the real wastewater. GL effectively removed pollutants in 48 h, 1% of the inoculum volume, and 50 rpm. The ZFET showed GL is non-toxic (LC50 is 209.95 mg/mL). In the morphology observation, pellets GL do not show major differences after treatment, showing potential to be used for a longer treatment time and to be re-useable in the system. GL offers advantages to removing PCs in water due to their non-specific extracellular enzymes that allow for the biodegradation of PCs and indicates a good potential in real-world applications as a favourable alternative treatment.